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Abstract
Purpose: Paraganglioma of the bladder is a rare neoplasm that usually 
presents with hypertension, headache and dizziness after micturition.
Case Presentation: We present the case of a 22-year-old man with typical 
symptoms of bladder paraganglioma. 
We performed the first robot-assisted laparoscopic tumorectomy without 
opening of the bladder mucosa. Additionally, we give an overview of the literature 
on minimally invasive approaches for bladder paraganglioma.
Conclusions: This article gives an overview of the symptoms, diagnostic 
tools and surgical treatment of bladder paraganglioma. It is a rare neoplasm 
that, however it has a typical presentation, can be easily missed based on 
patient history alone.
Keywords: Bladder paraganglioma; Pheochromocytoma; Minimally 
invasive surgical procedure
Introduction
Pheochromocytoma is a neuro-endocrine tumor that usually 
develops in the adrenal medulla. Extra-adrenal pheochromocytomas, 
also called paragangliomas (which account for 5% to 10% of 
pheochromocytomas), are most often found in the retroperitoneum, 
thorax and urinary bladder [1].
In the bladder wall it originates from the sympathetic plexus of 
the detrusor muscle. Bladder paragangliomas are extremely rare and 
constitute less than 0,05% of bladder tumors [2].
Typical symptoms are headache, palpitations, sweating, blurred 
vision and hypertension, all related to the act of micturition [1].
Diagnosis of a paraganglioma can be made in almost all patients 
with the demonstration of elevated measurements of plasma 
fractionated metanephrines and/or urinary plasma fractionated 
metanephrines and catecholamine’s (measured on a 24-hour urine 
collection).
Nuclear imaging in combination with computer tomography 
(CT) or magnetic resonance imaging (MRI) may be required to 
localize and fully delineate the extent of the disease.
Standard treatment is open partial or radical cystectomy. Minimal 
approaches are reported, but only in case reports.
We give a literature overview of all minimal-invasive cases and 
report the first case of a robot-assisted laparoscopic tumorectomy 
without opening the bladder.
Case Presentation
A 22-year-old man was referred to our urological department 
with complaints of severe headache, palpitations and dizziness after 
micturition occurring for 2 months. His complaints were initially this 
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severe, that he even refused to micturate and a transurethral catheter 
was placed in another hospital. His medical history and physical 
examination were completely normal. He had no urinary tract 
symptoms and no hematuria.
A 24-hour urine collection was performed and revealed an elevated 
amount of norepinephrine, together with elevated normetanephrine 
levels on a plasma sample, suggesting a paraganglioma.
Imaging
On ultrasonography, a 2x3-cm, slightly hypoechogenic mass was 
seen embedded in the left detrusor wall (Figure 1). On cystoscopy, 
the same mass was seen lying under the mucosa in the left side of the 
Figure 1: Ultrasonography.
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bladder (Figure 2). The lesion was estimated to be 5 cms away from 
the ureteral orifices.
A preoperatively performed 18F-fluorodeoxyglucose (FDG) 
positron emission tomography-computed tomography (PET-CT) 
scan showed no other PET-positive locations than the tumor in the 
bladder wall (Figure 3).
Pre-operative preparation
The patient was admitted three days before surgery. 
Preoperative preparation with alpha-adrenergic blocking agents 
(phenoxybenzamine 2x10mg/day) and pre-operative fluid loading 
(NaCl 0.9% 2L/24h) was given to restore the arterial blood pressure 
and intravascular volume to normal levels in order to prevent 
intraoperative and post-operative blood pressure fluctuations.
Operative technique
Under general anesthesia, a robot-assisted laparoscopy was 
performed using a 4-armed Da Vinci Si platform (Intuitive 
Surgical). We used our common “robot-assisted laparoscopic 
radical prostatectomy” patient positioning and port placement. 
The patient was installed in the lithotomy position. The procedure 
started with the placement of a 12-mm umbilical port for the camera. 
Pneumoperitoneum was achieved to a pressure of 12mmHg. Three 
additional 8-mm ports were placed under direct vision for the 3 robot 
arms (one in the right iliac fossa and 2 in the left iliac fossa) and a 
12-mm and 5-mm port for the assistant in the right iliac fossa and 
near to the camera port respectively. The patient was placed in 30O 
Trendelenburg position.
Inspection of the pelvis showed a well-marginated extraperitoneal 
mass in the left side of the bladder wall. The peritoneum was incised 
along the left medial umbilical ligament and lifted from the bladder 
and the mass. The left vas deferens, ureter and neurovascular bundle 
were identified. Then the dissection of the tumor was started, without 
direct manipulation to avoid hypertensive crisis. Blood supply to the 
tumor was sealed with an ultrasonic/bipolar device (Thunderbeat, 
Olympus). The mass was encircled with a combination of this sealing 
device and unipolar electrocoagulation. It showed to be well embedded 
in detrusor muscle; a safety margin of normal detrusor tissue was left 
on the tumor. However, there was a clear margin between the tumor 
and the bladder mucosa (Figure 4). As a result, the tumor could be 
macroscopically completely removed without opening the bladder. 
The specimen was put in an endocatch bag. The detrusor layer of the 
bladder was closed in two layers with an absorbable polyfilament 
suture (Vicryl 2/0). Filling the bladder with 200cc of water showed 
no leakage or diverticula. The specimen was removed by extending 
the incision of the 12-mm assistant port in the left fossa and sent for 
anatomopathological examination.
During the operation, there was only a short and slight rise in 
arterial blood pressure (160mmHg systolic) following minimal tumor 
manipulation that could be easily controlled by the administration 
Figure 2: Cystoscopic view.
Figure 3: FDG PET-CT.
Figure 4: Robot-assisted laparoscopic tumorectomy.
1. Intraperitoneal view of the bladder with tumoral mass (asterix) on the left 
side.
2. Starting dissection with identifying and controlling the vascularisation of the 
paraganglioma, with minimal manipulation of the tumour.
3. Detrusurotomy and dissecting the plane between tumour and bladder 
mucosa.
4. After removal of the tumour, the detrusor was closed with a running suture 
and a bladder filling test showed no leakage or diverticula.
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of antihypertensive drugs (sodium nitroprusside maximum of 5mcg/
kg/min).
Post-operative period
The patient made a quick post-operative recovery. Immediately 
post-operative, he was slightly hypotensive (90mmHg systolic), but 
within six hours the patient became and remained normotensive 
without any further medication. The urinary catheter was removed 
and he could leave the hospital on the second postoperative day 
without the need for further antihypertensive treatment.
Follow-up
A clinical follow-up visit 3 weeks postoperatively showed normal 
blood pressure and absence of symptoms relating to a hypertensive 
crisis or related to micturition. The patient showed no lower urinary 
tract symptoms related to the robot-assisted laparoscopic bladder 
surgery. A new 24-hour urine collection showed normal amounts of 
catecholamines.
Histopathological report
The final histopathological examination showed a paraganglioma 
embedded in detrusor muscle. The tumor measured 2.5x2.2x1.8 cm 
and there were negative surgical margins.
The tumoral mass consisted of groups of epithelioid cells 
lying in an organoid pattern (so called ‘Zellballen’ or cell clusters). 
These groups of cells were divided by thin fibrovascular septae. 
Immunohistochemical staining was used to confirm the definitive 
diagnosis. NSE (neuron-specific enolase), chromogranin and 
synaptophysine were strongly positive in the neoplastic cells, 
all neuroendocrine markers. SDHB (succinate dehydrogenase 
B-subunit)-staining was negative. Further exploration with genetic 
testing of the SDHB-gene is ongoing. There was no family history of 
pheochromocytoma/paraganglioma syndrome.
Discussion
Pheochromocytoma is a neuro-endocrine tumor that usually 
develops in the adrenal medulla. It is believed to arise from embryonic 
rests of chromaffin cells in the sympathetic plexus. Extra-adrenal 
pheochromocytomas, also called paragangliomas (which account 
for 5% to 10% of pheochromocytomas), are most often found in 
the retroperitoneum, thorax and urinary bladder [1]. Bladder 
paragangliomas are extremely rare and constitute less than 0,05% of 
bladder tumors [2]. They may occur more frequently with familial 
syndromes, including the von Hippel-Lindau (VHL) syndrome and 
succinate dehydrogenase B (SDHB) mutations [3].
Typical symptoms (present in 65% to 75% of patients) are 
headache, palpitations, sweating, blurred vision and hypertension, 
all related to the act of micturition. These symptoms are caused by 
an increased catecholamine release due to compression of the tumor 
in the bladder wall. Painless hematuria is also a common symptom, 
present in 55% to 58% of cases [1].
Diagnosis of a paraganglioma can be made in almost all patients 
with the demonstration of elevated measurements of plasma 
fractionated metanephrines and/or urinary plasma fractionated 
metanephrines and catecholamine’s (measured on a 24-hour urine 
collection).
Nuclear imaging in combination with computer tomography 
(CT) or magnetic resonance imaging (MRI) may be required 
to localize and fully delineate the extent of the disease. 
123/131I-metaiodobenzylguanidine (MIBG) single photon emission 
tomography (SPECT) is the conventional nuclear imaging technique 
for catecholamine-secreting tumors with a sensitivity of 80 – 95% and 
a specificity of 90 – 95% for non-metastatic paraganglioma. MIBG is 
a guanidine analogue, which is chemically similar to norepinephrine, 
and accumulates in adrenergic cells. Positron emission tomography 
(PET) with a variety of different tracers is superior to SPECT due 
to a higher sensitivity. Most paragangliomas, as the one in our case, 
show avidity for 18F-fluorodeoxyglucose (FDG), a glucose analogue 
- even in cases with a low proliferation rate and 6-(18F)fluoro-L-
dihydroxyphenylalanine (DOPA), the catecholamine precursor [4,5].
A biopsy is not recommended, as this could lead to a hypertensive 
crisis. A transurethral resection of the tumor entails the same risk.
Careful preoperative preparation is very important. Intravascular 
volume is contracted from the chronic sustained effect of the elevated 
catecholamine levels and should be re-expanded prior to removal 
of the neoplasm. If not, profound postoperative hypotension may 
result. Blood pressure is first controlled with alpha-blockade using 
phenoxybenzamine. Beta-blockade may be added to counteract the 
rebound tachycardia of the former [6]. Blood pressure control and 
a skilled anesthesia team are essential during operation. Surges in 
arterial blood pressure can be managed with titrated doses of sodium 
nitroprusside and nitroglycerine and boluses of esmolol and labetalol 
[7].
Standard treatment for localized or locally advanced bladder 
paraganglioma is surgery.
Approximately 10% of paragangliomas/pheochromocytomas are 
malignant. Physicians should be aware of poor prognostic indicators, 
such as large tumor size, advanced stage, SDHB-mutation and 
multifocal tumors [2]. If the tumor is limited to the bladder and is 
benign-looking, partial resection of the bladder can be performed, 
keeping the tumor intact [2]. Whether a pelvic lymphadenectomy 
should be done in every case is not clear. In case of proven malignancy, 
a pelvic lymphadenectomy can be performed in a secondary 
procedure. For more advanced disease (extravesical extension or 
clear pelvic lymphadenopathy), radical cystectomy with pelvic lymph 
nodal dissection has been advocated. In case of metastatic disease, 
surgical treatment is rarely curative, but it may prolong survival by 
reducing comorbid conditions, like severe hypertension [2]. Adjunct 
therapeutic options are limited, including 131I-MIBG radiation 
therapy for MIBG-avid metastases and combination chemotherapy 
(cyclophosphamide, vincristine and dacarbazine) [6].
Histologically, it is almost impossible to distinguish malignant 
and benign tumors. In the literature, cases are reported of patients 
who showed metastases of a malignant paraganglioma several 
decades after partial cystectomy [8]. For this reason, life-long follow-
up is always necessary, even when the initial lesion is solitary and the 
surgical resection is complete. A review in 2013 by Beilan et al. showed 
that 15 of 75 patients (20%) had local or distant disease recurrence 
after a mean follow-up of 35 months. Patients who presented with 
localized paraganglioma of the bladder had a significantly improved 
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survival compared to patients who presented with locally advanced or 
metastatic disease [2].
No clear guidelines exist on how to do follow-up. Examinations 
can include monitoring of urinary vanillylmandelic acid (VMA), 
metanephrine and catecholamine levels or imaging of abdomen and 
pelvis. Others recommend an annual MIBG-scan [6].
Because of the small number of cases and the smaller number of 
cases followed up, the prognosis of urinary bladder paraganglioma 
is not well established. Overall 5-year survival for patients with 
metastatic pheochromocytoma or paraganglioma is approximately 
50% [9].
More than 180 cases of bladder paraganglioma have been reported 
in the literature, but reports of minimally invasive surgical approach 
are sparse. In total, only 11 cases of (robot-assisted) laparoscopic 
partial cystectomy for bladder paraganglioma have been published 
[1,3,10-18] (Table 1). Kozlowski et al. performed the first laparoscopic 
partial cystectomy for a bladder paraganglioma in 2001 [11]. They 
combined a laparoscopic with a transurethral approach. Bozbora et 
al. were the first to only use laparoscopy for partial cystectomy for 
a bladder paraganglioma [1]. In 2009, Huang et al described a pre-
peritoneal laparoscopic approach for a bladder paraganglioma [14].
In 2010, Nayyar et al. reported the first robot-assisted partial 
cystectomy, distal ureterectomy and ureteric reimplantation for a 
paraganglioma in the vesicoureteric junction [12]. In 2011, Kang et 
al. also reported on a robot-assisted partial cystectomy for bladder 
paraganglioma [13]. In 2012, Luchey et al. performed a robot-assisted 
partial cystectomy and pelvic lymphadenectomy for metastatic bladder 
paraganglioma [10]. More recently, a video of partial cystectomy for 
bladder paraganglioma was published by Weintraub et al. [3]. To 
our knowledge, this case is only the fifth robot-assisted laparoscopic 
partial cystectomy performed for bladder paraganglioma. To be 
precise, we performed a robot-assisted laparoscopic tumorectomy for 
paraganglioma in the bladder wall.
Originally, we planned to do a classic partial cystectomy, but 
as the tumor presented with a clear margin between detrusor and 
bladder mucosa, we decided to leave the bladder mucosa unopened. 
This was made possible by the fine manipulation and perfect view 
that can be only achieved laparoscopically with a robot-assisted 
approach. This entails a shorter need for post-operative transurethral 
urinary catheterisation and significant reduction in morbidity for the 
patient. Clear resection margins were achieved and the tumor was 
removed intact, with results probably comparable to classic open 
surgical approach. Because of the low malignant potential of this type 
of tumors (<10%) and negative additional imaging techniques, we 
decided not to perform a pelvic lymphadenectomy. However, a life-
long follow-up is necessary.
Conclusion
Paraganglioma of the bladder wall is a very rare tumor with a 
typical presentation. However, it could be easily missed by clinicians 
who are not aware of this symptomatology. We present this case 
to demonstrate the feasibility of a minimally invasive approach for 
this kind of tumors. We performed a tumorectomy without the 
need for a partial cystectomy, which was made possible by a robot-
assisted laparoscopic intervention and resulted in minimal operative 
morbidity for the patient and complete relief of his symptoms.
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